www.benzinga.com
Open in
urlscan Pro
151.101.194.137
Public Scan
URL:
https://www.benzinga.com/pressreleases/22/04/p26479524/demetrix-and-evonik-sign-supply-agreement-for-cannabinoids
Submission: On April 08 via api from DE — Scanned from DE
Submission: On April 08 via api from DE — Scanned from DE
Form analysis
0 forms found in the DOMText Content
My account My Account Notifications Log In QQQ 350.630.98% DIA 348.140.63% SPY 449.020.06% TLT 124.481.59% GLD 181.250.5% BTC/USD 43032.460.9659% FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option Trades with Nic Chahine" Visit https://benzingabootcamp.clickfunnels.com/webinar-registrationww2muo3 FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option Trades with Nic Chahine" * * Data & APIs * Events * Marketfy * Premarket Contribute Sign in * News Earnings Guidance Dividends M&A Buybacks Legal Interviews Management Retail Sales Offerings IPOs Insider Trades Biotech/FDA Freight Politics Government Healthcare * Markets Pre-Market After Hours Movers ETFs Forex Cannabis Commodities Options Binary Options Bonds Futures CME Group Global Economics Previews Reviews Small-Cap Cryptocurrency Penny Stocks Digital Securities * Ratings Analyst Color Downgrades Upgrades Initiations Price Target * Ideas Trade Ideas Long Ideas Short Ideas Technicals From The Press Jim Cramer Rumors Best Stocks & ETFs Best Penny Stocks Best S&P 500 ETFs Best Swing Trade Stocks Best Blue Chip Stocks Best High-Volume Penny Stocks Best Small Cap ETFs * Fintech News Podcast Events Newsletter * Personal Finance Compare Online Brokers Stock Brokers Forex Brokers Futures Brokers Crypto Brokers Options Brokers ETF Brokers Mutual Fund Brokers Index Fund Brokers Bond Brokers Short Selling Brokers Stock Apps All Broker Reviews Insurance Auto Home Medicare Life Vision Dental Business Pet Health Motorcycle Renters Workers Comp Top Stocks Penny Stocks Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $50 Stocks Under $100 Alternative Investing Invest in Art Invest in Land Invest in Real Estate Invest in Wine Invest in Gold Mortgages Refinance Purchase Find a Mortgage Broker * Crypto Get Started Is Bitcoin a Good Investment? Is Ethereum a Good Investment? What is Blockchain Best Altcoins How to Buy Cryptocurrency? DeFi Crypto and DeFi 101 What is DeFi? Decentralized Exchanges Best DeFi Yield Farms Digital Securities NFTs NFT Release Calendar What is a Non-Fungible Token (NFT)? How to Buy Non-Fungible Tokens (NFTs) CryptoPunks Watchlist Are NFTs a Scam or a Digital Bubble? Best In Crypto Best Crypto Apps Best Crypto Portfolio Trackers Best Crypto Day Trading Strategies Best Crypto IRA Best Cryptocurrency Scanners Best Business Crypto Accounts Best Crypto Screeners * Cannabis News Earnings Interviews Deals Regulations Psychedelics * TV YouTube Video Podcasts * Trading School Personal Finance Compare Online Brokers Stock Brokers Forex Brokers Futures Brokers Crypto Brokers Options Brokers ETF Brokers Mutual Fund Brokers Index Fund Brokers Bond Brokers Short Selling Brokers Stock Apps All Broker Reviews Insurance Auto Home Medicare Life Vision Dental Business Pet Health Motorcycle Renters Workers Comp Top Stocks Penny Stocks Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $50 Stocks Under $100 Alternative Investing Invest in Art Invest in Land Invest in Real Estate Invest in Wine Invest in Gold Mortgages Refinance Purchase Find a Mortgage Broker Crypto Get Started Is Bitcoin a Good Investment? Is Ethereum a Good Investment? What is Blockchain Best Altcoins How to Buy Cryptocurrency? DeFi Crypto and DeFi 101 What is DeFi? Decentralized Exchanges Best DeFi Yield Farms Digital Securities NFTs NFT Release Calendar What is a Non-Fungible Token (NFT)? How to Buy Non-Fungible Tokens (NFTs) CryptoPunks Watchlist Are NFTs a Scam or a Digital Bubble? Best In Crypto Best Crypto Apps Best Crypto Portfolio Trackers Best Crypto Day Trading Strategies Best Crypto IRA Best Cryptocurrency Scanners Best Business Crypto Accounts Best Crypto Screeners Cannabis News Earnings Interviews Deals Regulations Psychedelics TV YouTube Video Podcasts Trading School My Stocks Tools Calendars Analyst Ratings Calendar Dividend Calendar Conference Call Calendar Earnings Calendar Economic Calendar FDA Calendar Guidance Calendar IPO Calendar M&A Calendar Retail Sales Calendar SPAC Calendar Stock Split Calendar Trade Ideas Insider Trades Trade Idea Feed Analyst Ratings Unusual Options Activity Short Interest Most Shorted Largest Increase Largest Decrease Calculators Margin Calculator Premium QQQ 350.630.98% DIA 348.140.63% SPY 449.020.06% TLT 124.481.59% GLD 181.250.5% BTC/USD 43032.460.9659% FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option Trades with Nic Chahine" Visit https://benzingabootcamp.clickfunnels.com/webinar-registrationww2muo3 FREE Webinar this Sunday 7pm ET Register Now "How to Win 90% of Your Option Trades with Nic Chahine" DEMETRIX AND EVONIK SIGN SUPPLY AGREEMENT FOR CANNABINOIDS by PRWeb April 5, 2022 11:30 AM | 3 min read [TODAY ONLY] Get 50% OFF and get 2 bear market-beating options trades straight to your inbox and SMS every month! Click Here Now to Get Started! Demetrix and German global specialty chemicals company Evonik, announce a supply agreement for cannabinoids to be used in beauty and personal care products. The first product, CBG (cannabigerol) will be entering the market in 2022. BERKELEY, Calif. (PRWEB) April 05, 2022 Demetrix and German global specialty chemicals company Evonik, announce a supply agreement for cannabinoids to be used in beauty and personal care products. The first product, CBG (cannabigerol) will be entering the market in 2022. -------------------------------------------------------------------------------- LIVE RIGHT NOW ON YOUTUBE: How to Use Simple Options To Make Money in Volatile Markets with Wall Street Veteran Matt Maley Click Here NOW to Watch! -------------------------------------------------------------------------------- Powered By 10 See Which American Lithium Company Saw 707% Growth After They Fight Back Against China Share Next Stay Coupling Demetrix's proven production technology and Evonik's leadership position as a sustainable specialties partner to the top beauty and personal care brands, this multi-year relationship focuses on bringing cannabinoids to global markets. "Evonik is a global leader in supplying innovative solutions to the beauty and personal care markets in more than 100 countries," says Cynthia Bryant, Demetrix CBO. "This partnership speaks to the growing demand for high purity cannabinoids because of the benefits they can provide for consumers." "Evonik Care Solutions is the sustainability specialties partner. Sustainability drives our development of products and processes, and we are furthering our mission by choosing solutions from biotechnology companies like Demetrix. The industry-leading team at Demetrix and their deep experience in producing bioactives sustainably complements our formulation and market expertise in beauty and personal care," says Franck Michoux, Director of Strategy for Cosmetic Actives Ingredients. "We are eager to work with Demetrix and bring more of the over 100 cannabinoids to market." Demetrix provides access to rare bioactive ingredients that its research has shown to hold promise for health and wellness benefits. The company is initially focusing on cannabinoids, a class of natural compounds that hold tremendous potential for the health and beauty industry. Demetrix ingredients do not have many of the common impurities found with plant extraction that can create undesirable effects in consumer products. For more information about Demetrix's bioactive products and sustainability goals, visit http://www.demetrix.com. For more information about Evonik's sustainability goals for the beauty and personal care industry, visit http://www.evonik.com/personal-care. About Demetrix Demetrix is a biotechnology company that believes in the power of science to make the world a better place. The company produces health and wellness products backed by science, including rare, ultra-high purity cannabinoids for pharmaceutical and consumer applications. Demetrix's team of industry-leading experts has enabled the company to bring its first ingredient to market in less than 5 years from startup – the fastest achieved in the industry. The company is pioneering the study of the more than 100 rare cannabinoids and their interactions with the human body. Demetrix is venture-backed and headquartered in Berkeley, California. About Evonik Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow. The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €3.56 billion in 2021 with about 5,300 employees. For the original version on PRWeb visit: https://www.prweb.com/releases/2022/4/prweb18597787.htm IF YOU ARE NOT USING THIS TRADING STRATEGY, YOU ARE LEAVING MONEY ON THE TABLE... If you are blindly looking up and trading stocks the way 99% of traders are, you are missing on HUGE potential returns. Even new traders who started following this options trading strategy instantly began seeing returns they wouldn't have had otherwise. With even two trades per month with this strategy, you will start seeing the difference in your trading account. Don't waste any more time "guessing" and "getting lucky". Click Here to See if you Qualify for Benzinga Options! © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. Posted In: Create a Watchlist FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet. Click to Get Started Beat the Market With Our Free Pre-Market Newsletter Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter